NEW! If you don't understand one of the words in this article,
just double-click it.
A window will open with a definition from CancerWEB's On-line Medical Dictionary. If the double-click feature
doesn't work in your browser, you can enter the word below:
Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.
November 15, 2007
Stigma Affects 20 Percent of HIV Vaccine Trial Participants
HIV vaccine researchers need to place more emphasis on protecting vaccine trial participants’ privacy and reducing the negative social consequences to them. Stigma affects nearly 20 percent of trial participants, suggests a report in the November issue of Journal of Acquired Immune Deficiency Syndromes (aidsmap.com, 11/15).
In a study of 5,417 trial participants, 18 percent reported that they’d experienced some range of negative social impacts such as unintentional disclosure or problems with housing, medical care, relationships, employment, insurance or travel.
The most common social impact reported was negative reactions from friends, family members and partners that the vaccine could infect participants.
